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ABSTRACT: 
Aim To test if training and support, financial reimbursement, and option of referring screen 
positive patients to an internet-based method of giving advice (eBI) can increase primary 
health care providers’ delivery of AUDIT-C based screening and advice to heavy drinkers.  
Design Cluster randomized factorial trial with 12-week implementation and measurement 
period.  
Setting Primary health care units (PHCU) in different locations throughout Catalonia, 
England, Netherlands, Poland and Sweden.  
Participants 120 PHCU, 24 in each of Catalonia, England, Netherlands, Poland and Sweden. 
Interventions PHCUs were randomized to one of eight groups: care as usual, training and 
support (TS), financial reimbursement (FR), and eBI; paired combinations of TS, FR and eBI, 
and all of FR, TS and eBI.  
Outcome measures Measurements The primary outcome measure is was the proportion of 
eligible adult (age 18+ years) patients screened during a 12-week implementation period. 
Secondary outcome measures are were proportion of screen positive patients advised; and, 
proportion of consulting adult patients given an intervention (screening and advice to 
screen positives) during the same 12-week implementation period. 
Results Findings During a 4-week baseline measurement period, 5.9 (95% CI 3.4 to 8.4) per 
100 adult patients consulting per PHCU were screened for their alcohol consumption. Based 
on the factorial design, the ratio of the logged proportion screened during the 12-week 
implementation period was 1.48 (95% CI 1.13 to 1.95) in PHCU that received TS versus PHCU 
that did not receive TS; for FR, the ratio was2.00 (95% CI 1.56 to 2.56). The option of referral 
to eBI did not lead to a higher proportion of patients screened. The ratio for TS plus FR 
was2.34 (95% CI 1.77 to 3.10), and the ratio for TS plus FR plus eBI was1.68 (95% CI 1.11 to 
2.53).   
Conclusions Providing primary health care units with training, support and financial 
reimbursement for delivering AUDIT-C based screening and advice to heavy drinkers 
increases screening for alcohol consumption.  Providing primary health care units with the 
option of referring screen positive patients to an internet-based method of giving advice 
does not appear to increase screening for alcohol consumption. 
 
Trial registration ClinicalTrials.gov. Trial identifier: NCT01501552   
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Introduction 
 
Alcohol consumption is a wholly or contributory cause for more than 200 diseases, injuries and other 
health conditions with three digit ICD-10 codes [1]. The cardio-protective effect of low-risk patterns 
of alcohol consumption disappears in the presence of heavy episodic drinking [2]. Globally, alcohol is 
the sixth most important risk factor for ill-health and premature death [3]. Reduction in alcohol 
consumption is essential to achieve global targets of reducing deaths from non-communicable 
diseases by 25% between 2010 and 2025 [4]. Heavy drinkers who reduce their drinking reduce their 
risk of mortality in comparison to those who continue heavy drinking [5-6]. The higher the level of 
drinking, the stronger the effects of a given reduction [7]. Systematic reviews demonstrate that 
primary health care based screening and brief advice programmes are effective in reducing alcohol 
consumption and related harm, with the evidence strongest for adults, and less so for adolescents 
[8-10].   
 
Many national and international guidelines recommend routine screening in primary health care and 
the offer of advice to screen positive patients (e.g. [11-13]).  However, in many jurisdictions there is 
a large gap between need and provision of advice. Elsewhere, we have shown that only 5.3% of 
eligible patients consulting their primary health care provider over a four-week period were 
screened for their alcohol consumption (average across Catalonia, England, Netherlands, Poland and 
Sweden) [14].  It is possible to increase the proportion of eligible patients screened.  A meta-
regression analysis of 29 studies found that professional and patient-oriented implementation 
strategies could improve screening (standardized effect 0.53;95%-CI (confidence interval) 0.28 to 
0.78) and advice (standardized effect 0.64;95%-CI 0.27 to 1.02) rates [15].  
 
In this paper, we report on a five country study that tested the hypothesis that the provision of each 
of training and support, financial reimbursement, and the option of referring identified heavy 
drinking patients to an internet based method of delivering advice (eBI) [16], singly and in 
combination to primary health care providers, will increase the proportion of adult patients (aged 
18+ years) screened and given brief advice, compared to no provision. In our study, the unit of 
randomization, intervention, and analysis is the primary health care unit (PHCU) and not the 
individual primary health care provider working within a PHCU.    
 
 
Methods 
 
Design 
 
In a cluster randomized 2x2x2 factorial trial [for trial protocol, see 17 – there were no trial 
deviations], the impact of the three different implementation strategies on screening and advice for 
heavy drinking operationalized by AUDIT-C [see 18] was studied (Fig. 1). Data were collected 
between August 2012 and December 2013. 
 
Fig.1. Trial Flow chart. 
 
 
Participants 
 
PHCUs with approximately 5,000-20,000 registered patients from five jurisdictions (Catalonia, 
England, Netherlands, Poland and Sweden) were the unit of randomization and implementation. 
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PHCUs who agreed to participate in the study were volunteers drawn from administrative or 
academic registries of PHCUs at national or regional levels. Eligible providers in each PHCU included 
any fully trained full or part-time medical practitioner, nurse or PHCU assistant with a permanent 
appointment working in the PHCU. Not all providers within each PHCU participated in the study.  
  
Implementation strategies 
 
PHCU were recruited between March and July 2013. After formal agreement of the PHCU to take 
part in the trial, a 4-week baseline measurement period took place.  After a 2-6-week gap, the 12-
week implementation period occurred, with the start date for each country between November 
2012 and May 2013. All seven groups received the same input as controls but with additional 
components added. 
 
1. Control Group: The control group was given a package containing a summary card of the national 
guideline recommendations for screening and advice for hazardous and harmful alcohol 
consumption, without demonstration. In Poland, the card was adapted from the PHEPA guidelines 
[19-20].  Instructions were given on how to complete the trial record sheet, and providers were 
asked to screen all adult patients (aged 18+ years) with AUDIT-C.   
 
2. Training and support (TS): In addition to receiving the same package as the control group, the TS 
group was offered two initial 1-2 hours face-to-face educational trainings, and one (10-30 minutes) 
telephone support call to the lead PHCU contact person during the 12-week implementation period. 
Each country used an adapted existing country-based TS package. In Poland, the TS package was 
based on the PHEPA training programme [21].  
 
3. Financial reimbursement (FR): The financial reimbursement group was paid for screening and 
advice activities during the 12-week implementation period. In Catalonia, a maximum ceiling rate of 
€250 per provider was established, and fees were calculated based on the average individual 
performance of the 12-week implementation period. In England, fees were €6 per screening and €25 
per advice, with a maximum ceiling rate of €2200 per PHCU. In the Netherlands, fees were €9 per 
screening and €13.50 per advice, with a maximum ceiling rate of €1250 per PHCU. In Poland, fees 
were €1.25 per screening and €10 per advice, with no ceiling rate. In Sweden, fees were €2 per 
screening and €15 per advice with a maximum ceiling rate of €3300 per PHCU.  
 
4. eBI: In addition to receiving the same package as the control group, the eBI group was asked to 
refer identified at risk patients with an e-leaflet to an approved eBI specific package, which was 
country specific, or, for Poland based on the WHO e-SBI programme. 
 
5. TS and financial reimbursement (TSFR): The TS and FR group received the control group package, 
training and support, and the financial reimbursement as described above. 
 
6. TS and eBI (TSeBI): The TS and eBI group received the control group package, training and support 
as above, and were asked to refer identified at risk patients to eBI as above. 
 
7. Financial reimbursement and eBI (FReBI): The FR and eBI group received the control group 
package, were asked to refer identified at risk patients to eBI, and received the same financial 
reimbursement as for FR, even if providers only referred screen-positive patients to eBI. 
 
8. TS, financial reimbursement and eBI (TSFReBI: The TS, FR and eBI group received the control group 
package and training and support as above. They were asked to refer identified at risk patients to eBI 
and received financial reimbursement as described in group 7 above. 
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PHCUs were asked to screen all adult patients (aged 18+ years) who consulted the PHCU using a 
paper version of AUDIT-C, except in Catalonia, where a computerized version was used. Screen 
positives were defined in Catalonia and England as men and women who scored ≥5 on AUDIT-C, and 
in Poland, Netherlands and Sweden as men who scored ≥5 and women who scored ≥4 on AUDIT-C. 
PHCU were asked to deliver brief advice of 5-15 minutes duration to screen positives, with the 
length and format of the advice based on country specific guidelines or, for Poland, the European 
guidelines developed by PHEPA [19]. Providers who were allocated to eBI activity were asked to 
refer screen-positive patients to a computerized advice programme, taking a few minutes to explain 
why the patient ought to log on to the site.  
 
Outcomes 
 
Screening and brief advice activity was measured at two time points: during the 4-week baseline 
period, and during the 12-week implementation period, using paper tally sheets completed by the 
providers, with the exception of Catalonia, where electronic patient records were completed by the 
providers. The tally sheets included AUDIT-C questions, AUDIT-C scores, and tick boxes to indicate 
the type of advice (oral advice, an advice leaflet, referral to the eBI programme, or referral for advice 
to another provider in or outside the PHCU) that was delivered. For the one PHCU that dropped out 
of the study after the baseline measurement, data outcome measurements during the 12-week 
implementation period were set as the rates for the baseline measurement period (intention to 
treat analysis).  
 
The primary outcome measure was the proportion of eligible patients screened, the number of 
patients screened divided by the number of adult consultations of the participating providers per 
PHCU. The secondary outcome measures were the proportion screen positives advised, the number 
of AUDIT-C positive patients that received one or more of oral advice, an advice leaflet, referral to 
the eBI programme, or referral for advice to another provider in or outside the PHCU, divided by the 
total number of screen positive patients per PHCU; and the proportion of consulting adult patients 
intervened (screening and advice to screen positives), the number of AUDIT-C positive patients that 
received one or more of oral advice, an advice leaflet, referral to the eBI programme, or referral for 
advice to another provider in or outside the PHCU, divided by the total number of adult 
consultations of the participating providers per PHCU.  
 
As distributional assumptions of the outcome measures were violated, a natural logarithm 
transformation was undertaken. As this approach creates some issues with outcomes with a zero 
value, 0.001 was added to each proportion. At baseline, 7/124 PHCU returned a zero proportion of 
patients screened, and 5/124 PHCU returned a zero proportion of screen-positive patients advised. 
During the 12-week implementation period, no PHCU returned a zero proportion of patients 
screened, and 3/124 PHCU returned a zero proportion of screen-positive patients advised. In order 
to test the validity of this assumption a sensitivity analysis was undertaken using the exact 
proportions but excluding those PHCU with an outcome of zero.  
 
 
Randomization and blinding 
 
Randomization of the PHCU took place after formal agreement of the PHCU to take part in the trial. 
The PHCUs were randomly allocated to one of the eight groups by the ODHIN coordinating centre in 
Barcelona, using Microsoft Office Excel computerized randomization. Stratified randomization by 
country was used to ensure equal numbers of 15 PHCUs per eight allocation group, with equal 
numbers per allocation group per country (three PHCU per allocation group per country). The 
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country-based research teams were informed of the allocation after collection of the baseline 
measurement.  The PHCU were informed by the country-based research teams of the allocation 
after collection of the baseline measurement.  
 
Sample size 
 
It was estimated that 56 PHCUs (seven per eight allocation groups) with a minimum of 1,000 adult 
patients per month would be needed for a 80% chance of detecting an increase in the proportion of 
patients screened from 8% to at least 12% (ICC (Intraclass Correlation Coefficient) = 0.029) and that 
120 PHCUs (15 per eight allocation groups) would be needed for a 80% chance of detecting an 
increase in the proportion of consulting adult patients given an intervention from 4% to at least 6% 
(ICC = 0.029) (alpha = 0.05). As country was used as stratification criteria each country included a 
minimum of 24 PHCU [17, data based on 22].  
 
 
Statistical methods 
 
The primary outcome for the study was the proportion screened over the 12-week implementation 
period and this was analysed by allocated group.  Distributional assumptions were assessed and 
transformations were undertaken where appropriate. The analysis was conducted on an intention to 
treat basis. The primary outcome was analysed as a generalised linear model with proportion 
screened in the 4-week baseline period incorporated as a covariate. As the study is hierarchical in 
nature with PHCU nested within country, a multi-level approach was employed using country with 
random intercepts and slopes. Means by group and 95% confidence intervals (95% CI) are presented 
for each allocated group. Mean differences and 95% CI are presented with reference to the control 
group. In order to aid interpretation, the ratio of proportion screened in the allocated group versus 
the control group and associated 95% CI are also presented and an overall level of significance 
presented. 
 
As the study was conceived as a factorial design, a second analysis explored individual, TS, FR, EBI, 
and combined, TSFR, TSEBI, FREBI, TSFREBI factors of the intervention (For examples of factorial 
designs, see [23-25]). These were analysed in a similar manner with an exploration for potential 
interactions using a step-up approach and interpreted using the r-square statistic. Where 
interactions were identified they were incorporated into the regression equation. Additional 
secondary analysis was conducted on the proportion of screen positives who were provided with 
advice and the proportion of all patients who consulted who were screened, and if screen positive, 
given advice. Results are presented in a similar manner to the primary outcome. Analysis was 
conducted using Stata and MLWin. 
 
RESULTS 
 
In total, 618 PHCU were approached across the five countries to reach the required sample size of 
120 PHCU’s, 24 per country. The overall enrolment rate of 19.4% varied across countries: Catalonia 
65%, England 7%, Netherlands 7%, Poland 46%, Sweden 24%. The mean number of patients 
registered in each PHCU was 10,000. There was a mean of 1500 adult (age 18+ years) consultations 
per PHCU during the 4-week baseline period, mean age 53 years (SD=6), of whom 55% were men. 
Just over half of the participating providers per PHCU were doctors (55%), 38% nurses, and 7% 
practice assistants. The mean age of the participating providers per PHCU was 47 years (SD=5), and 
74% were women.    
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During the 4-week baseline period, the mean proportion of eligible patients screened per PHCU was 
0.059 (95%CI 0.034 to 0.084); the mean proportion of screen positives advised per PHCU was 0.737 
(95% CI 0.606 to 0.868); and the mean proportion consulting adult patients given an intervention per 
PHCU was 0.011 (95%CI 0.005 to 0.017). Table 1 shows the mean and standard error of proportion 
screened, advised and intervened over the 4-week baseline and 12-week implementation periods. 
Table 2 illustrates that the proportion of patients screened, advised and intervened generally 
dropped off for most allocation groups during the 12-week implementation period.  
 
 
Table 3 shows the mean proportion screened during the 12-week implementation period by 
allocated group. Significant effects were observed for the TS, TSFR and TSFREBI groups compared to 
the control group and in all cases the effect favoured the intervention group over the control. Table 
4 shows that a similar effect was observed for these groups for the proportion of screen positives 
receiving advice but no significant effects were observed for the proportion receiving an 
intervention (proportion of consulting adult patients given an intervention (screening and advice to 
screen positives)).  
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Table 1: Mean proportion and standard error of those screened, advised and intervened during 4-
week baseline period and 12-week implementation period by allocated group. 
 
  
Mean proportion (SE)* 
 
Baseline 12-week implementation 
 
Screen 
Control 
TS 
FR 
EBI 
TS+FR 
TS+EBI 
FR+EBI 
TS+FR+EBI 
 
 
Advice 
Control 
TS 
FR 
EBI 
TS+FR 
TS+EBI 
FR+EBI 
TS+FR+EBI 
 
 
Intervene 
Control 
TS 
FR 
EBI 
TS+FR 
TS+EBI 
FR+EBI 
TS+FR+EBI 
 
 
 
0.0681 (0.0212) 
0.0676 (0.0125) 
0.0667 (0.0136) 
0.0970 (0.0231) 
0.0524 (0.0095) 
0.0452 (0.0124) 
0.0587 (0.0183) 
0.0568 (0.0141) 
 
 
 
0.7961 (0.0517) 
0.7921 (0.0712) 
0.6824 (0.0796) 
0.6925 (0.0802) 
0.7520 (0.0943) 
0.7728 (0.0617) 
0.7564 (0.0964) 
0.6628 (0.0661) 
 
 
 
0.0134 (0.0035) 
0.0149 (0.0044) 
0.0097 (0.0018) 
0.0167 (0.0035) 
0.0125 (0.0033) 
0.0128 (0.0028) 
0.0121 (0.0039) 
0.0071 (0.0017) 
 
 
0.0349 (0.0064) 
0.0548 (0.0122) 
0.1182 (0.0322) 
0.0574 (0.0139) 
0.1758 (0.0557) 
0.0367 (0.0106) 
0.0659 (0.0188) 
0.0786 (0.0151) 
 
 
 
0.6270 (0.0820) 
0.8743 (0.0364) 
0.8288 (0.0516) 
0.8062 (0.0596) 
0.9048 (0.0356) 
0.7960 (0.0926) 
0.7627 (0.0790) 
0.8626 (0.0304) 
 
 
 
0.0056 (0.0013) 
0.0108 (0.0035) 
0.0180 (0.0044) 
0.0098 (0.0021) 
0.0346 (0.0098) 
0.0091 (0.0022) 
0.0078 (0.0018) 
0.0154 (0.0029) 
 
  
* N=15 for all groups, with the following exceptions:  
Screen, 12-week, FR=14 (one PHCU dropped out) 
Advice, baseline, TSeBI=11; Control, TSFR=13; TS, eBI, FReBI, TSFReBI=14 (when proportion screened=0, 
proportion advised cannot be calculated) 
Advice, 12-week, FR=14 (one PHCU dropped out) 
Intervene, 12-week, FR=14 (one PHCU dropped out) 
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Table 2: Mean proportion and standard error of those screened, advised and intervened during 
weeks 1-4, 5-8 and 9-12 of 12-week implementation period by allocated group. 
 
 Mean proportion (SE) 
Weeks of 12-week implementation period 
1-4 5-8 9-12 
Screen     
Control 0.0388 (0.00716) 0.0344 (0.00720) 0.0256 (0.00573) 
TS 0.0640 (0.01409) 0.0553 (0.01338) 0.0491 (0.00989) 
FR 0.1428 (0.04558) 0.1119 (0.03378) 0.0999 (0.02403) 
EBI 0.0718 (0.01931) 0.0574 (0.01045) 0.0515 (0.01405) 
TS+FR 0.1905 (0.05974) 0.1541 (0.04246) 0.1503 (0.04557) 
TS+eBI 0.0493 (0.01126) 0.0406 (0.01042) 0.0371 (0.00771) 
FR+eBI 0.1035 (0.02756) 0.0504 (0.01310) 0.0521 (0.01791) 
TS+FR+eBI 0.1390 (0.04531) 0.0761 (0.01413) 0.0697 (0.01339) 
Advice     
Control 0.7147 (0.08130) 0.7124 (0.08246) 0.5851 (0.10382) 
TS 0.8850 (0.03129) 0.8379 (0.04846) 0.8797 (0.05458) 
FR 0.8610 (0.03788) 0.8692 (0.05882) 0.7561 (0.07170) 
EBI 0.7886 (0.06196) 0.8188 (0.06933) 0.8046 (0.06362) 
TS+FR 0.9253 (0.02497) 0.8925 (0.03735) 0.8603 (0.06547) 
TS+eBI 0.7940 (0.08886) 0.8239 (0.07955) 0.8891 (0.04522) 
FR+eBI 0.7786 (0.07417) 0.7686 (0.08424) 0.8404 (0.06984) 
TS+FR+eBI 0.8747 (0.03319) 0.8796 (0.03597) 0.8466 (0.03991) 
Intervene     
Control 0.0071 (0.00164) 0.0056 (0.00107) 0.0040 (0.00141) 
TS 0.0134 (0.00322) 0.0125 (0.00459) 0.0100 (0.00325) 
FR 0.0184 (0.00440) 0.0177 (0.00473) 0.0178 (0.00514) 
EBI 0.0115 (0.00283) 0.0087 (0.00139) 0.0093 (0.00247) 
TS+FR 0.0384 (0.01158) 0.0304 (0.00765) 0.0274 (0.00720) 
TS+eBI 0.0118 (0.00297) 0.0080 (0.00182) 0.0084 (0.00219) 
FR+eBI 0.0134 (0.00332) 0.0063 (0.00125) 0.0060 (0.00180) 
TS+FR+eBI 0.0246 (0.00547) 0.0142 (0.00312) 0.0103 (0.00203) 
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Table 3: Mean natural log of proportion screened during 12-week implementation period, mean 
difference versus control (95% CI), ratio versus control (95% CI) and significance value by allocated 
group. 
 
  
Mean during 12-week 
implementation period 
(95% CI) 
 
 
Difference versus control  
(95% CI) 
 
Ratio versus control  
(95% CI) 
 
Sig. 
 
Control 
TS 
FR 
EBI 
TS+FR 
TS+EBI 
FR+EBI 
TS+FR+EBI 
 
 
-3.589 (-4.493; -2.686) 
-3.233 (-4.136; -2.330) 
-2.732 (-3.636; -1.827) 
-3.389 (-4.292; -2.485) 
-2.238 (-3.141; -1.335) 
-3.379 (-4.283; -2.475) 
-3.248 (-4.151; -2.345) 
-2.604 (-3.507; -1.701) 
 
- 
0.357 (-0.098; 0.812) 
0.858 (0.392; 1.324) 
0.201 (-0.260; 0.662) 
1.351 (0.897; 1.805) 
0.210 (-0.245; 0.666) 
0.342 (-0.112; 0.795) 
0.986 (0.532; 1.439) 
 
1.00 
1.43 (0.37; 2.25) 
2.36 (1.48; 3.76) 
1.22 (0.77; 1.94) 
3.86 (2.45; 6.08) 
1.23 (0.78; 1.95) 
1.41 (0.89; 2.21) 
2.68 (1.70; 4.22) 
 
- 
0.123 
<0.001 
0.390 
<0.001 
0.362 
0.139 
<0.001 
 
 
 
Table 4: Mean natural log of proportion advised and given intervention during 12-week 
implementation period, mean difference versus control (95% CI), ratio versus control (95% CI) and 
significance value by allocated group. 
 
  
Mean during 12-week 
implementation period 
(95% CI) 
 
 
Difference versus 
control  
(95% CI) 
 
Ratio versus control  
(95% CI) 
 
Sig. 
 
Advice 
 
Control 
TS 
FR 
EBI 
TS+FR 
TS+EBI 
FR+EBI 
TS+FR+EBI 
 
Intervention 
 
Control 
TS 
FR 
EBI 
TS+FR 
TS+EBI 
FR+EBI 
TS+FR+EBI 
 
 
 
 
-5.362 (-6.010; -4.714) 
-4.773 (-5.422; -4.125) 
-4.453 (-5.104; -3.802) 
-4.877 (-5.526; -4.228) 
-3.808 (-4.456; -3.160) 
-4.926 (-5.574; -4.227) 
-4.887 (-5.536; -4.239) 
-4.183 (-4.813; -3.534) 
 
 
 
-0.951 (-1.559; -0.344) 
-0.146 (-0.729; 0.436) 
-0.227 (-0.810; 0.356) 
-0.266 (-0.850; 0.317) 
-0.114 (-0.720; 0.491) 
-0.761 (-1.420; -0.101) 
-0.725 (-1.312; -0.138) 
-0.154 (-0.738; 0.429) 
 
 
 
- 
0.588 (0.149; 1.028) 
0.909 (0.461; 1.356) 
0.485 (0.044; 0.925) 
1.554 (1.114; 1.994) 
0.436 (-0.004; 0.876) 
0.474 (0.034; 0.915) 
1.179 (0.738; 1.620) 
 
 
 
- 
0.805 (-0.037; 1.647) 
0.725 (-0.116; 1.566) 
0.685 (-0.159; 1.529) 
0.837 (-0.022; 1.697) 
0.191 (-0.703; 1.084) 
0.227 (-0.622; 1.076) 
0.797 (-0.044; 1.638) 
 
 
 
1.00 
 1.80 (1.16; 2.80) 
2.48 (1.59; 3.88) 
1.62 (1.04; 2.52) 
4.73 (3.05; 7.34) 
1.55 (0.99; 2.40) 
1.61 (1.03; 2.50) 
3.25 (2.09; 5.05) 
 
 
 
1.00 
2.24 (0.96; 5.19) 
2.06 (0.89; 4.79) 
1.98 (0.85; 4.61) 
2.31 (0.98; 5.46) 
1.21 (0.50; 2.96) 
1.25 (0.54; 2.93) 
2.22 (0.96; 5.14) 
 
 
 
- 
0.009 
<0.001 
0.031 
<0.001 
0.052 
0.035 
<0.001 
 
 
 
- 
0.061 
0.091 
0.110 
0.056 
0.673 
0.598 
0.063 
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Based on the factorial design, the absence or presence of different elements of the intervention was 
explored in relation to the primary and secondary outcomes. Significant positive effects were 
observed for the proportion screened for those interventions involving TS, FR, TSFR and TSFREBI 
(table 5). No effects were observed in terms of the proportion of screen positives given advice 
during the 12-week implementation period (table 6). In terms of the proportion receiving an 
intervention, significant positive effects were observed for TS, FR, TSFR and TSFREBI, table 7. 
 
 
Table 5: Mean natural log of proportion screened during 12-week implementation period, mean 
difference (95% CI), ratio (95% CI) and significance value by presence or absence of factor. 
 
  
Mean during 12-week 
implementation period 
(95% CI) 
 
 
Difference versus absent  
(95% CI) 
 
Ratio versus absent 
(95% CI) 
 
Sig. 
TS 
Absent 
Present 
FR 
Absent 
Present 
EBI 
Absent 
Present 
TSFR 
Absent 
Present 
TSEBI 
Absent 
Present 
FREBI 
Absent 
Present 
TSFREBI 
Absent 
Present 
 
 
-3.253 (-4.180; -2.325) 
-2.859 (-3.786; -1.932) 
 
-3.398 (-4.306; -2.489) 
-2.705 (-3.613; -1.796) 
 
-2.951 (-3.852; -2.050) 
-3.155 (-4.056; -2.255) 
 
-3.269 (-4.196; -2.342) 
-2.418 (-3.342; -1.494) 
 
-3.076 (-3.990; -2.162) 
-2.998 (-3.899; -2.077) 
 
-3.098 (-4.013; -2.183) 
-2.924 (-3.836; -2.012) 
 
-3.119 (-4.037; -2.202) 
-2.601 (-3.525; -1.677) 
 
 
- 
0.394 (0.120; 0.667) 
 
- 
0.693 (0.444; 0.942) 
 
- 
-0.204 (-0.483; 0.075) 
 
- 
0.851 (0.569; 1.133) 
 
- 
0.088 (-0.240; 0.417) 
 
- 
0.174 (-0.149; 0.498) 
 
- 
0.518 (0.106; 0.930) 
 
1.00 
1.48 (1.13; 1.95) 
 
1.00 
2.00 (1.56; 2.56) 
 
1.00 
0.82 (0.62; 1.08) 
 
1.00 
2.34 (1.77; 3.10) 
 
1.00 
1.09 (0.77; 1.52) 
 
1.00 
1.19 (0.86; 1.64) 
 
1.00 
1.68 (1.11; 2.53) 
 
 
 
0.05 
 
 
<0.001 
 
 
0.150 
 
 
<0.001 
 
 
0.596 
 
 
0.287 
 
 
0.014 
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Table 6: Mean natural log of proportion given brief advice during 12-week implementation period, 
mean difference (95% CI), ratio (95% CI) and significance value by presence or absence of factor. 
 
  
Mean during 12-week 
implementation period 
(95% CI) 
 
 
Difference versus absent  
(95% CI) 
 
Ratio versus absent 
(95% CI) 
 
Sig. 
TS 
Absent 
Present 
FR 
Absent 
Present 
EBI 
Absent 
Present 
TSFR 
Absent 
Present 
TSEBI 
Absent 
Present 
FREBI 
Absent 
Present 
TSFREBI 
Absent 
Present 
 
 
-0.536 (-0.839; -0.232) 
-0.270 (-0.582; 0.043) 
 
-0.509 (-0.823; -0.196) 
-0.309 (-0.614; -0.004) 
 
-0.352 (-0.661; -0.044) 
-0.461 (-0.772; -0.150) 
 
-0.498 (-0.749; -0.247) 
-0.135 (-0.567; 0.297) 
 
-0.402 (-0.653; -0.152) 
-0.419 (-0.873; 0.035) 
 
-0.394 (-0.649; -0.139) 
-0.442 (-0.870; -0.013) 
 
-0.445 (-0.679; -0.210) 
-0.153 (-0.756; 0.451) 
 
 
- 
0.266 (-0.170; 0.701) 
 
- 
0.200 (-0.238; 0.638) 
 
- 
-0.109 (-0.547; 0.329) 
 
- 
0.363 (-0.137; 0.862) 
 
 
-0.017 (-0.536; 0.503) 
 
- 
-0.048 (-0.547; 0.452) 
 
- 
0.292 (-0.356; 0.939) 
 
1.00 
1.30 (0.18; 2.02) 
 
1.00 
1.22 (0.79; 1.89) 
 
1.00 
0.90 (0.58; 1.43) 
 
1.00 
1.44 (0.87; 2.37) 
 
1.00 
0.98 (0.58; 1.65) 
 
1.00 
0.95 (0.58; 1.57) 
 
1.00 
1.34 (0.70; 2.56) 
 
 
0.229 
 
 
0.367 
 
 
0.624 
 
 
0.153 
 
 
0.950 
 
 
0.850 
 
 
0.374 
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Table 7: Mean natural log of proportion given alcohol intervention during 12-week 
implementation period, mean difference (95% CI), ratio (95% CI) and significance value by 
presence or absence of factor. 
 
  
Mean during 12-week 
implementation period 
(95% CI) 
 
 
Difference versus absent  
(95% CI) 
 
Ratio versus absent 
(95% CI) 
 
Sig. 
TS 
Absent 
Present 
FR 
Absent 
Present 
EBI 
Absent 
Present 
TSFR 
Absent 
Present 
TSEBI 
Absent 
Present 
FREBI 
Absent 
Present 
TSFREBI 
Absent 
Present 
 
 
-4.901 (-5.535; -4.267) 
-4.424 (-5.058; -3.789) 
 
-4.984 (-5.615; -4.353) 
-4.331 (-4.961; -3.700) 
 
-4.597 (-5.225; -3.970) 
-4.721 (-5.349; -4.094) 
 
-4.885 (-5.525; -4.246) 
-3.993 (-4.634; -3.352) 
 
-4.693 (-0.191; 0.454) 
-4.561 (-5.198; -3.925) 
 
-4.700 (-5.331; -4.096) 
-4.542 (-5.179; -3.905) 
 
-4.728 (-5.362; -4.095) 
-4.188 (-4.856; -3.520) 
 
 
- 
0.477 (0.212; 0.743) 
 
- 
0.694 (0.401; 0.906) 
 
- 
-0.124 (-0.402; 0.154) 
 
- 
0.893 (0.616; 1.170) 
 
- 
0.132 (-0.191; 0.454) 
 
- 
0.158 (-0.164; 0.480) 
 
- 
0.540 (0.130; 0.950) 
 
1.00 
1.61 (1.24; 2.10) 
 
1.00 
2.00 (1.49; 2.47) 
 
1.00 
0.88 (0.67; 1.17) 
 
1.00 
2.44 (1.85; 3.22) 
 
1.00 
1.14 (0.83; 1.74) 
 
1.00 
1.17 (0.85; 1.62) 
 
1.00 
1.72 (1.14; 2.58) 
 
 
0.001 
 
 
<0.001 
 
 
0.380 
 
 
<0.001 
 
 
0.420 
 
 
.334 
 
 
0.010 
 
 
 
Sensitivity analysis suggested the addition of 0.001 to the observed outcome in order to transform 
the outcomes had no significant impact on the results. 
 
 
Discussion 
 
Overall findings 
 
During a 4-week baseline measurement period, screening for alcohol consumption was delivered by 
primary health care providers to just under 6% of adult consultations, with 74% of screen positives 
given advice.  Overall, brief advice for AUDIT-C screen positive patients was delivered by primary 
health care providers to 11 per 1,000 adult consultations.  An AUDIT-C cut-off score of 5 is 
equivalent to a consumption level of about 20 grams of alcohol per day [26].  Amongst EU citizens 
aged 15-64 years, 230/1,000 women regularly drink 20 grams of alcohol or more per day and 300/1, 
000 men regularly drink 40 grams of alcohol or more per day [27]. Of those screened in the ODHIN 
study, 330/1000 were AUDIT-C positive; this suggests that only some 3% of those who might benefit 
from brief advice were receiving it.  
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We found the provision of training and support and of financial reimbursement led to a higher 
proportion of consulting adult patients being screened for alcohol consumption. The offer of eBI 
referral did not impact this proportion. We consider the lack of an impact of eBI due to a lack of 
familiarization by the providers of eBI, and perhaps lack of trust in its impact. We did not find 
evidence of extra synergy from combined strategies, compared with single strategies alone.  
 
The proportion of screen positive patients given brief advice was very high at baseline (74%). This is 
likely to explain our inability to demonstrate an impact of training and support and financial 
reimbursement in changing the proportion of screen positive patients given brief advice.  
 
 
Strengths and weaknesses 
 
One strength of the present study is its factorial design, which ensured that it had sufficient power 
to detect small changes with a relatively small number of PHCU (120). Another strength of the study 
is that it was conducted across five different European jurisdictions, with differing health system 
financing and management structures.    
 
One weakness of the study is that the involved PHCUs were volunteers drawn from administrative or 
academic registries until the required sample size was achieved. Data is not available to indicate 
whether or not the volunteer PHCUs were representative of PHCUs in the five countries as a whole. 
However, we do know that general practitioners in the present study had higher role security (mean 
21.59, SD 3.20) when working with drinkers than representative samples of general practitioners 
from the same countries (mean 20.55, SD 2.94), anova, F=25.4, p<0.001; and, had higher therapeutic 
commitment when working with drinkers (mean 26.76, SD 4.54) than the representative sample 
(mean 24.67, SD 4.74), anova, F=57.75, p<0.001 [14]. Role security and therapeutic commitment are 
measures of attitudes toward working with drinkers, and thus the volunteer PHCUs seem more 
motivated to working with drinkers than PHCUs from the same country in general.   
 
A second weakness of the present study was that the outcome measures were of provider 
behaviour, rather than patient outcomes. Another weakness of the study is that the record sheet to 
measure AUDIT-C included the options for giving advice. In itself, this is an organizational 
intervention to support provider behaviour that, whilst equal across all intervention groups, 
probably led to the high advice rates for positive screens (74%). Completion of the record sheet was 
made by the provider, and the study had no independent check that the advice was actually carried 
out, or that a screen or advice were done without being registered on the record sheet.  Another 
weakness of the study is the short time span of the implementation period. Resourcing of the study 
constrained the implementation and analysis period to twelve weeks. During this twelve weeks, as 
indicated by table 2, the proportion of patients screened, advised and intervened tended to drop off 
in most allocation groups, suggesting that the impact of the implementation strategies might be 
quite short-lived. Our study was restricted to adults (aged 18+ years), as the evidence for the 
effectiveness of primary health care delivered brief advice is much stronger for adults than for 
adolescents. Thus, we do not know if our interventions would have increased the proportion of 
adolescents screened and advised.   
 
Comparison with other studies  
 
The impact of training and support is similar to the results of the World Health Organization four 
country (Australia, Belgium, Catalonia and England) collaborative randomized controlled trial which 
demonstrated the effectiveness of training and support in promoting screening and Intervention for 
hazardous and harmful alcohol consumption [22, 28]. In the WHO study, the odds ratios for the 
15 
 
impact of high training and support on increasing higher screening proportions (defined as 20% or 
more) was 2.2 (95% CI=1.3 to 3.1) and on increasing higher intervention proportions (defined as 10% 
or more) was 2.8 (95% CI = 1.6 to 4.0) [32]. 
 
In contrast, a cluster randomized controlled trial in the Netherlands, which investigated the impact 
of an improvement programme combining professional, organisation, and patient directed activities, 
failed to find an impact of the intervention on the number of adult patients who received screening 
and advice [29]. One of the given reasons for failing to find an impact was sub-optimal 
implementation of the programme due to difficulties in recruiting GPs and in motivating GPs for 
participation in the tailored parts of the programme.  
 
Implications for service commissioners and policy makers  
 
The potential of screening and brief advice programmes to improve health (and sometimes to 
reduce costs) has been shown elsewhere [30-31].  With strong government support for alcohol brief 
interventions, reinforced by financial and performance management arrangements, guidance and 
strategic leadership, as well as training, it is possible to increase alcohol screening and brief 
interventions (see [13, 32-34]).  
 
We included the option of referral to an eBI programme as one of the implementation strategies in 
the belief that this might encourage higher screening activity, as providers did not then have to 
deliver a brief advice themselves. The failure of this strategy to impact on any of the outcomes 
would suggest that providers in this study are not yet ready to refer patients to eBI programmes. 
Elsewhere, we have shown that providers who more strongly believe that heavy drinking is the 
drinker’s own responsibility report that they are less likely to engage in delivering brief advice [35]. 
Thus, for the time being, it might be preferable to market eBI programmes directly to drinkers, 
rather than through their primary health care providers, whilst more studies are undertaken to 
explore how referral to eBI could be best organized and implemented.  
 
Based on the ODHIN findings, we would recommend that all jurisdictions could consider providing 
support for alcohol brief advice based on training and guidance, financial and performance 
management arrangements, and strategic leadership, so as to increase the volume of brief 
interventions delivered to heavy drinking patients in primary health care.   
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